Smathorn Thakolwiboon is a Neurology physician affiliated with Wheaton Franciscan Healthcare. OpenAlex indexes 82 publications with 566 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 West Ave S
La Crosse, WI 546018806
Telephone
608-785-0940Provider last certified this registry record 23 Aug 2023.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20256 payments
- Janssen Research & Development, LLCProgram year202313 payments
- Novartis Pharmaceuticals CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
79.9%Cholinesterase Inhibitor18%Donepezil Hcl70%Rivastigmine31%Part D<11 patientsPotassium Channel Blocker8.4%Dalfampridine Er100%Part D≥18 patients+ 17 more classes in this area
Musculoskeletal
9.6%gamma-Aminobutyric Acid-ergic Agonist7.8%Baclofen100%Part D≥20 patientsCentral alpha-2 Adrenergic Agonist1.8%Tizanidine Hcl100%Part D<11 patientsCancer & immunology
7.1%CD20-directed Cytolytic Antibody2.5%Kesimpta Pen100%Part D<11 patientsSphingosine 1-phosphate Receptor Modulator2.1%Fingolimod100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- MOG antibody-associated disease epidemiology in Olmsted County, USA, and Martinique
Journal of Neurology
2025 - Autoimmune encephalitis: recovery, residual symptoms and predictors of long-term sequelae
Journal of Neurology Neurosurgery & Psychiatry
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”